edoc

Items where Author is "Phillips, P. P. J."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2017
Number of items: 2.

2017

Boeree, M. J. and Heinrich, N. and Aarnoutse, R. and Diacon, A. H. and Dawson, R. and Rehal, S. and Kibiki, G. S. and Churchyard, G. and Sanne, I. and Ntinginya, N. E. and Minja, L. T. and Hunt, R. D. and Charalambous, S. and Hanekom, M. and Semvua, H. and Mpagama, S. G. and Manyama, C. and Mtafya, B. and Reither, K. and Wallis, R. S. and Venter, A. and Narunsky, K. and Mekota, A. and Henne, S. and Colbers, A. and van Balen, G. P. and Gillespie, S. H. and Phillips, P. P. J. and Hoelscher, M.. (2017) High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis : a multi-arm, multi-stage randomised controlled trial. The Lancet infectious diseases, 17 (1). pp. 39-49.

Aarnoutse, R. E. and Kibiki, G. S. and Reither, K. and Semvua, H. H. and Haraka, F. and Mtabho, C. M. and Mpagama, S. G. and van den Boogaard, J. and Sumari-de Boer, I. M. and Magis-Escurra, C. and Wattenberg, M. and Logger, J. G. M. and Te Brake, L. H. M. and Hoelscher, M. and Gillespie, S. H. and Colbers, A. and Phillips, P. P. J. and Plemper van Balen, G. and Boeree, M. J.. (2017) Pharmacokinetics, tolerability and bacteriological response of 600, 900 and 1200 mg rifampicin daily in patients with pulmonary TB. Antimicrobial agents and chemotherapy, 61 (11). e01054-17.

This list was generated on Thu Nov 14 03:47:47 2019 CET.